Respiratory Medicine
Volume 98, Issue 10 , Pages 990-999 , October 2004

Single-isomer R-salbutamol is not superior to racemate regarding protection for bronchial hyperresponsiveness

  • Kerstin Naidu Sjöswärd

      Affiliations

    • Department of Anaesthesiology, Faculty of Health, Institute of Medicine and Care, University Hospital, SE-581 85 Linköping, Sweden
    • Corresponding Author InformationCorresponding author. Fax: +46-13-22-18-09
    • ,
  • Mounira Hmani

      Affiliations

    • Faculty of Medicine, Laboratory of Human Molecular Genetics, Sfax, Tunisia
    • Department of Cell Biology, Faculty of Health, Linköping, Sweden
    • ,
  • Anette Davidsson
    • ,
  • Peter Söderkvist

      Affiliations

    • Department of Cell Biology, Faculty of Health, Linköping, Sweden
    • ,
  • Birgitta Schmekel

      Affiliations

    • Department of Clinical Physiology, Faculty of Health, Linköping, Sweden

Received 30 October 2003 ,Accepted 3 March 2004.

References 

  1. Waldeck B. Beta-Adrenoceptor agonists and asthma-100 years of development. Eur J Pharmacol. 2002;445:1–12
  2. Schmekel B, Rydberg I, Norlander B, et al.  Stereoselective pharmacokinetics of S-salbutamol after administration of the racemate in healthy volunteers. Eur Respir J. 1999;13:1230–1235
  3. Gleich GJ, Jacoby DB, Fryer AD. Eosinophil-associated inflammation in bronchial asthma (a connection to the nervous system). Int Arch Allergy Immunol. 1995;107:205–207
  4. Van Schoor J, Joos GF, Pauwels RA. Indirect bronchial hyperresponsiveness in asthma (mechanisms, pharmacology and implications for clinical research). Eur Respir J. 2000;16:514–533
  5. D’Amato M, Vitiani LR, Petrelli G, et al.  Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes, A population study. Am J Respir Crit Care Med. 1998;158:1968–1973
  6. Swystun VA, Gordon JR, Davis EB, et al.  Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J Allergy Clin Immunol. 2000;106:57–64
  7. Cloosterman SG, Bijl-Hofland ID, van Herwaarden CL, et al.  A Placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-Agonists in allergic asthmatic patients. Chest. 2001;119:1306–1315
  8. Wahedna I, Wong CS, Wisniewski AFZ, et al.  Asthma control during and after cessation of regular beta2-agonists treatment. Am Rev Respir Dis. 1993;148:707–712
  9. Nelson HS. Clinical experience with levalbuterol. J Allergy Clin Immunol. 1999;104:s77–s84
  10. Handley D. The asthma-like pharmacology and toxicology of (S)-isomers of β agonists. J Allergy Clin Immunol. 1999;104:s69–s76
  11. Sanjar S, Morley J. Airway hyperreactivity. Lancet. 1988;2:160–161
  12. Sanjar S, Kristersson A, Mazzoni L, et al.  Increased airway reactivity in the guinea-pig follows exposure to intravenous isoprenaline. J Physiol. 1990;425:43–54
  13. Small KM, McGraw DW, Liggett SB. Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol. 2003;43:381–411
  14. Israel E, Drazen JM, Liggett SB, et al.  The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med. 2000;162:75–80
  15. NHLBI/WHO Workshop Report. Global strategy for asthma management and prevention: Global Initiative for Asthma (GINA), National Institute of Health, Public Nb, 95-3659, 1995.
  16. Gumbhir-Shah K, Kellerman DJ, DeGraw S, et al.  Pharmacokinetics and pharmacodynamics of cumulative single doses of inhaled salbutamol enantiomers in asthmatic subjects. Pulm Pharmacol Ther. 1999;12:353–362
  17. Roca J, Burgos F, Sunyer J, et al.  References values for forced spirometry. Group of the European Community Respiratory Health Survey. Eur Respir J. 1998;11:1354–1362
  18. Peterson CGB, Enander I, Nystrand J, et al.  Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy. 1990;21:561–567
  19. Naidu Sjöswärd K, Josefsson M, Ahlner J, et al.  Metabolism of salbutamol differs between asthmatics and healthy volunteers. Pharmacol Toxicol. 2003;92(1):27–32
  20. Coughtrie MW, Gilissen RA, Shek B, et al.  Phenol sulphotransferase SULT1A1 polymorphism (molecular diagnosis and allele frequencies in Caucasian and African populations). Biochem J. 1999;337(Pt 1):45–49
  21. Peng CT, Chen JC, Yeh KT, et al.  The relationship among the polymorphisms of SULT1A1, 1A2 and different types of cancers in Taiwanese. Int J Mol Med. 2003;11:85–89
  22. Ronaghi M, Uhlen M, Nyren P. A sequencing method based on real-time pyrophosphate. Science 1998;281 363, 365.
  23. Handley DA, McCullough JR, Crowther SD, et al.  Sympathomimetic enantiomers and asthma. Chirality. 1998;10:262–272
  24. Pennings HJ, Wouters EF. Effect of inhaled beclomethasone dipropionate on isocapnic hyperventilation with cold air in asthmatics, measured with forced oscillation technique. Eur Respir J. 1997;10:665–671
  25. Boulton DW, Fawcett JP. The pharmacokinetics of levosalbutamol (what are the clinical implications?). Clin Pharmacokinet. 2001;40:23–40
  26. Verleden GM, Belvisi MG, Rabe KF, et al.  Beta 2-adrenoceptor agonists inhibit NANC neural bronchoconstrictor responses in vitro. J Appl Physiol. 1993;74:1195–1199
  27. Hall IP, Wheatley A, Wilding P, et al.  Association of Glu 27 β2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet. 1995;345:1213–1214
  28. Liggett SB. Molecular and genetic basis of β2-adrenergic receptor function. J Allergy Clin Immunol. 1999;104:s42–s46
  29. Ulbrecht M, Hergeth MT, Wjst M, et al.  Association of beta(2)-adrenoreceptor variants with bronchial hyperresponsiveness. Am J Respir Crit Care Med. 2000;161:469–474
  30. Chong LK, Chowdry J, Ghahramani P, et al.  Influence of genetic polymorphisms in the beta2-adrenoceptor on desensitization in human lung mast cells. Pharmacogenetics. 2000;10:153–162
  31. Schmekel B, Smith HJ. The diagnostic capacity of forced oscillation and forced expiration techniques in identifying asthma by isocapnic hyperpnoea of cold air. Eur Respir J. 1997;10:2243–2249
  32. Salome CM, Thorpe CW, Diba C, et al.  Airway re-narrowing following deep inspiration in asthmatic and nonasthmatic subjects. Eur Respir J. 2003;22:62–68
  33. Gayrard P, Orehek J, Grimaud C, et al.  Bronchoconstrictor effect of a deep inspiration in patients with asthma. Am Rev Respir Dis. 1975;111:433–439
  34. Goldman MD. Clinical application of forced oscillation. Pulm Pharmacol Ther. 2001;14:341–350
  35. Boulton DW, Fawcett JP. Pharmacokinetics and pharmacodynamics of single oral doses of albuterol and its enantiomers in humans. Clin Pharmacol Ther. 1997;62:138–144

PII: S0954-6111(04)00108-8

doi: 10.1016/j.rmed.2004.03.005

Respiratory Medicine
Volume 98, Issue 10 , Pages 990-999 , October 2004

Article Tools

* Image Usage & Resolution